SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED Shandong Xinhua Pharmaceutical Company Limited Stock Shenzhen S.E.
Equities
000756
CNE000000BG1
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16 CNY | +1.91% |
|
+4.71% | -21.49% |
| Sales 2022 | 7.5B 1.04B | Sales 2023 | 8.1B 1.12B | Capitalization | 10.81B 1.5B |
|---|---|---|---|---|---|
| Net income 2022 | 411M 56.83M | Net income 2023 | 497M 68.72M | EV / Sales 2022 | 2.12 x |
| Net Debt 2022 | 225M 31.13M | Net Debt 2023 | 440M 60.89M | EV / Sales 2023 | 1.39 x |
| P/E ratio 2022 |
11.8
x | P/E ratio 2023 |
7.3
x | Employees | 7,104 |
| Yield 2022 |
2.78% | Yield 2023 |
4.76% | Free-Float | 60.55% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +1.91% | ||
| 1 week | +4.71% | ||
| Current month | -2.79% | ||
| 1 month | -3.73% | ||
| 3 months | -10.96% | ||
| 6 months | -20.83% | ||
| Current year | -21.49% |
1 week
15.15
16.00
1 month
14.9917.14
Current year
13.4520.88
1 year
13.4526.85
3 years
7.3248.85
5 years
6.2248.85
10 years
3.9548.85
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 117 M€ | +1.27% | - | |
| 0.00% | 34 M€ | +2.43% | - | |
| 0.00% | 7 M€ | +0.11% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-28 | 16 | +1.91% | 8 112 810 |
| 24-04-26 | 15.7 | +0.38% | 8,168,565 |
| 24-04-25 | 15.64 | +1.36% | 8,539,651 |
| 24-04-24 | 15.43 | +0.19% | 5,122,830 |
| 24-04-23 | 15.4 | +0.26% | 5,533,500 |
End-of-day quote Shenzhen S.E., April 28, 2024
More quotes
SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED is a China-based company principally engaged in the development, production and distribution of chemical bulk drugs, preparations and medical intermediates. The Companyâs main products include metamizole sodium, caffeine, aminopyrine, aspirin, hydrocortisone, pipemidic acid, ibuprofen, L-dopa, pipemidic acid tablets, compound liquorice tablets and nimodipine tablets. The Company distributes its products in domestic market and to overseas markets, including the Americas, Europe and others.
Sector
Pharmaceuticals
Calendar
2024-08-22
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +26.08% | 661B | |
| +26.74% | 566B | |
| -6.57% | 352B | |
| +18.70% | 332B | |
| +3.71% | 283B | |
| +13.43% | 231B | |
| +4.71% | 200B | |
| -9.53% | 195B | |
| -4.29% | 145B |
- Stock Market
- Equities
- 719 Stock
- 000756 Stock
